This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biovail, Valeant Agree to Merge

TORONTO ( TheStreet) --- Specialty drugmakers Biovail (BVF) and Valeant (VRX - Get Report) have agreed to merge.

The combined company will be called Valeant Pharmaceuticals International. The new Valeant will have a "significantly expanded presence in North America and operations in eight other countries, working across four growth platforms," the companies said in a statement Monday.

Under the terms of the merger, Valeant stockholders will receive 1.7809 Biovail shares for each Valeant share they own plus a one-time special cash dividend of $16.77 a share.

Upon completion of the merger, which is expected to occur before the end of 2010, Biovail stockholders will own about 50.5% of the combined company while Valeant stockholders will own roughly 49.5%.

The companies said they will pay by Dec. 31 an additional dividend of $1 a share, after which the new Valeant doesn't intend to pay dividends.

-- Reported by Joseph Woelfel in New York.

Follow on Twitter and become a fan on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VRX $87.99 1.20%
AAPL $95.21 0.23%
FB $102.56 3.00%
GOOG $694.25 2.40%
TSLA $148.21 -0.03%


Chart of I:DJI
DOW 16,035.03 +20.65 0.13%
S&P 500 1,870.43 +18.22 0.98%
NASDAQ 4,342.8310 +74.0680 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs